News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One Labs Announces New Director
July 08, 2021
Vancouver, British Columbia, Canada – July 8, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the...
Read more
Company News
New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
June 19, 2021
Vancouver, British Columbia, Canada – June 19, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
CORE ONE LABS RETAINS CANADA’S HIGHEST-RANKED IP LAW FIRM TO ASSIST WITH PATENT FILINGS
June 18, 2021
Vancouver, British Columbia, Canada – June 18, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq
June 16, 2021
Vancouver, British Columbia, Canada – June 16, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) advises that in preparation of a potential...
Read more
Company News
CORE ONE LABS INC. ANNOUNCES EXPECTED DELAY AND PROVIDES UPDATE RELATED TO FILING OF ANNUAL REPORT PURSUANT TO NATIONAL POLICY 12-203 – MANAGEMENT CEASE TRADE ORDERS
June 14, 2021
Vancouver, British Columbia, Canada – June 14, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or ”Core One”)....
Read more
Company News
Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
June 12, 2021
Vancouver, British Columbia, Canada – June 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more